Lymphangitis occurring after intralesional Candida antigen injection for verruca vulgaris.
Verruca vulgaris is a common dermatological disease with many treatment options including destructive modalities and more recently, immunotherapy. Intralesional injections of Candida antigen have been described as a safe and effective treatment with the most common adverse reactions including local reactions (burning, blistering, peeling), local erythema, and pain at the injection site. We describe the first reported case of lymphangitis after intralesional Candida antigen injection for verruca vulgaris in a healthy 18-year-old woman. The lymphangitis rapidly resolved with ibuprofen and cold compresses. Physicians should be aware of this potential adverse reaction when using this treatment modality and should be familiar with appropriate treatment of subsequent lymphangitis.
University of Cincinnati, Department of Dermatology. Zubritly@ucmail.uc.edu.
Lindsey
L
Zubritsky
Ali
A
Alikhan
D000293:Adolescent; D000946:Antigens, Fungal / Q000009:adverse effects* / Q000276:immunology; D002175:Candida / Q000276:immunology; D017679:Cryotherapy; D005260:Female; D006229:Hand Dermatoses / Q000628:therapy*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D015552:Injections, Intralesional; D008205:Lymphangitis / Q000139:chemically induced*; D014860:Warts / Q000628:therapy*
D000946:Antigens, Fungal; D007155:Immunologic Factors